LOSIRAL LEZRA FEMARA Leena AROMEK AROMEK LETARA

Dose: 2.5 mg
Single Dose: 2.5 (2.5)
Frequency: 24 hourly
Route: PO
Instructions:

Dose: Not applicable in this age group
Single Dose:
Frequency:
Route:
Instructions:

Dose: Not applicable for this age group
Single Dose:
Frequency:
Route:
Instructions:

belongs to Benzonitrile. It belongs to Antineoplastic Agent, Aromatase Inhibitor pharmacological group.The Molecular Weight of Letrozole is 285.30.

Letrozole

The severe or irreversible adverse effects of Letrozole, which give rise to further complications include Thromboembolic disorder.The symptomatic adverse reactions produced by Letrozole are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Diarrhea, Myalgia, Dyspnea, Abdominal pain, Rashes, Coughing, Nausea and vomiting, Hot flushes, SomnolenceX, Vaginal dryness, Stevens Johnson syndrome, dizziness, Bone fracture.

Letrozole is primarily indicated in conditions like Breast cancer, and can also be given in adjunctive therapy as an alternative drug of choice in Advanced breast cancer in postmenopausal women.

No data regarding the interactions of Letrozole was found.

Elevations of SGPT and SGOT Increases Serum Bilirubin

Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store Below 40°C. Protect from Sunlight and Moisture.

Letrozole should be used with caution in patients with any allergies (especially drug allergies) or liver disease. Limit alcohol intake as it may increase the side effects of this drug. It should be used with caution while performing tasks requiring mental alertness (e.g.driving), because this drug may cause drowsiness. It is not recommended for use during pregnancy.